Skip to main content
OpenTrials

Clinical trial condition

Lymphoproliferative Disorders

Explore clinical trials studying Lymphoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,057 public trials 2,038 recruiting studies
Refine in advanced search Browse all conditions

Lymphoproliferative Disorders trial results

Completed

S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers

NCT00996047

Conditions
Blast Crisis, Bone Marrow Diseases, Carcinogenesis, +42 more
Locations
  • Providence Cancer Center at Providence Hospital Mobile, Alabama, United States
  • Providence Cancer Center Anchorage, Alaska, United States
  • Arizona Cancer Center at University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Hembree Mercy Cancer Center at St. Edward Mercy Medical Center Fort Smith, Arkansas, United States
View all 280 locations
View Trial Details
Completed

S9805, High-Dose Melphalan Plus Peripheral Stem Cell Transplantation Followed by Interferon Alfa in Treating Patients With Waldenstrom's Macroglobulinemia

NCT00003416

Conditions
Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +14 more
Locations
  • MBCCOP - University of South Alabama Mobile, Alabama, United States
  • CCOP - Greater Phoenix Phoenix, Arizona, United States
  • Veterans Affairs Medical Center - Phoenix (Hayden) Phoenix, Arizona, United States
  • Veterans Affairs Medical Center - Tucson Tucson, Arizona, United States
View all 84 locations
View Trial Details
Completed

S0528 Lapatinib and Everolimus in Treating Patients With Advanced Solid Tumors or Non-Hodgkin's Lymphoma

NCT00352443

Conditions
Blood Protein Disorders, Burkitt Lymphoma, Cardiovascular Diseases, +43 more
Locations
  • USC/Norris Comprehensive Cancer Center and Hospital Los Angeles, California, United States
  • University of California Davis Cancer Center Sacramento, California, United States
  • University of Colorado Cancer Center at UC Health Sciences Center Aurora, Colorado, United States
  • Lucille P. Markey Cancer Center at University of Kentucky Lexington, Kentucky, United States
View Trial Details
Completed

S9628 Dexamethasone Plus Interferon Alfa in Treating Patients With Primary Systemic Amyloidosis

NCT00002849

Conditions
Amyloidosis, Blood Protein Disorders, Cardiovascular Diseases, +17 more
Locations
  • Rebecca and John Moores UCSD Cancer Center La Jolla, California, United States
  • Veterans Affairs Medical Center - San Francisco San Francisco, California, United States
  • CCOP - Christiana Care Health Services Wilmington, Delaware, United States
  • Lombardi Cancer Center Washington D.C., District of Columbia, United States
View all 40 locations
View Trial Details
Completed

First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers

NCT01120457

Conditions
Acute Myelogenous Leukemia, Chronic Disease, Chronic Lymphocytic Leukemia, +22 more
Locations
  • Uab Comprehensive Cancer Center Birmingham, Alabama, United States
  • Uc San Diego Moores Cancer Center La Jolla, California, United States
  • Usc - Norris Comprehensive Cancer Center And Hospital Los Angeles, California, United States
  • Ucla-Division Of Hematology/Oncology Los Angeles, California, United States
View Trial Details
Completed

RAD001 Combined With CHOP in Newly Diagnosed Peripheral T-cell Lymphomas

NCT01198665

Conditions
Anaplastic Large Cell Lymphoma, ALK-negative, Angioimmunoblastic T Cell Lymphoma, Cutaneous T Cell Lymphoma, +15 more
Locations
  • National Cancer Center Goyang-si, Kyoungki-do, South Korea
  • Samsung Medical Center Seoul, South Korea
  • Asan Medical Center Seoul, South Korea
  • Korea Cancer Center Hospital Seoul, South Korea
View Trial Details

Related conditions